VERVE THERAPEUTICS INC - COMMON STOCK

CUSIP: 92539P101

Q1 2024 13F Holders as of 31 Mar 2024

Security type / class
Equity / COMMON STOCK
Total 13F shares
10,470,585
Total 13F value
$139,049,369
Holder snapshot 5 signals
Share change
+2,168,340
SEC-reported price per share
$13.28
Number of holders
2
Value change
+$28,795,555
Number of buys
2
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
85,151,237

Security key

92539P101

Report period

Q1 2024

Institutions

2

Top holders

4

92539P101 full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2024 Previous quarter: Q4 2023 Verve Therapeutics, Inc. SEC filings

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of 92539P101 - VERVE THERAPEUTICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
4/4
Latest evidence
31 Dec 2023
13F Lead comparable stake: 5.2%

Quick read

BlackRock Finance, Inc. leads the comparable SEC ownership view at 5.2%.

4 of 4 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Finance, Inc.'s linked filing trail.
Comparable ownership Top 4
BlackRock Finance, Inc. 5.2%
STATE STREET CORP 4.5%
CITADEL ADVISORS LLC 0.53%
RENAISSANCE TECHNOLOGIES LLC 0.19%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-4 of 4 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock Finance, Inc.
13F
Company
13F
5.2%
$61,830,606
4,435,481 shares
 — 31 Dec 2023
STATE STREET CORP
13F
Company
13F
4.5%
$53,902,690
3,866,764 shares
 — 31 Dec 2023
CITADEL ADVISORS LLC
13F
Company
13F
0.53%
$6,270,490
449,820 shares
 — 31 Dec 2023
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
0.19%
$2,294
164,567 shares
 — 31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
2
Shares
10,470,585
Rows available
2
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 holders
2
Q1 2024 holders
2
Holder diff
0
Investor Q4 2023 Shares Q1 2024 Shares Share Diff Share Chg % Q4 2023 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .